[1] 何波,段永壮,郝丽文,等.早期功能锻炼对髌骨粉碎性骨折术后膝关节功能恢复的影响:附65例报告[J].山东医药,2006,46(30):39-40.
[2] 陆裕朴.部分切除术治疗髌骨横断及一端粉碎骨折的远期疗效[J].中华骨科杂志,1995,5(5):280-281.
[3] 王亦璁,孟继懋,郭小恒.骨与关节损伤[M].2版.北京:人民卫生出版社,1995:680-687.
[4] Wu CC,Tai CL,Chen WJ.Patellar tension band wiring:a revised technique.Archives of orthopaedic and traumatic surgery[J].Arch Orthop Trauma Surg,2001,121(1/2):12-16.
[5] 孙沪霞,钱国正,张春才,等.镍钛聚髌器治疗髌骨骨折生物力学特性的研究[J].中华骨科杂志,1992,12(5):361-363.
[6] 张春才,王家林,朱丽华,等.NT-PC的生物力学特性与髌骨骨折研究[J].医学生物力学,1995,10(2):36-40.
[7] 张春才,王家林,肖剑,等.镍钛聚髌器治疗髌骨骨折及生物力学特性[J].骨与关节损伤杂志,1996,11(2):78-80. (本文编辑 刘璐)即使可行手术切除,其复发率也相当高;因此,化疗对于晚期胃癌就显得格外重要,但至今仍没有公认的规范标准化的化疗方案
[8] [2]
[9] [3]
[10] [4]
[11] [5]
[12] [6]
[13] [7]
[14] [8]
[15] [7]
[1] Zhao JG,Qiu F,Xiong JP,et al.A phase Ⅱstudy of modified FOLFOX as frist-line chemotherapy in elderly patients with advanced gastric cancer[J].Anticancer Drugs,2009,20(4):28.
[2] Van Custem E,Moiseyenko VM,Tjulandin S,et al.Phase Ⅲstudy of docetaxel and cisplatin plus fluorouracil compared with the 325 study Group[J].J Clin Oncol,2006,24(31):4991-4997.
[3] 安富荣,戈升荣,祝德秋.卡培他滨的药理特性及临床应用进展[J].中国新药与临床杂志,2002,21(8):503-507.
[4] Kang HJ,Chang HM,Kim TW,et al.A phase Ⅱ study of paclitaxel and capecitabine as a frist-line combination chemotherapy for advanced gastric cancer[J].Br J Cancer,2008,98(2):316-322.
[5] Kang YK,Kang WK,Shin DB,et al.Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer:a randomized phase Ⅲ noninferiority trial[J].Ann Oncol,2009,20(4):666-673.
[6] Okines AF,Norman AR,MaCloud P,et al.Meta-analysis of the REAL-2 and ML 17032 trials:evaluating capecitabine based combination chemotherapy and infused 5-fluorouracil based combination chemotherapy for the treatment of advanced oesophagogastric cancer[J].Ann Oncol,2009,20(9):1529-1534.
[7] Venturini M,Del Mastro L,Garrone O,et al.Phase Ⅰdose findings study of capecitabine in combination with docetaxeland epirubicinas first line chemotherapy for advanced beast cancer[J].Ann Oncol,2002,13(4):546-552.
[8] Cunningham D,Starling N,Rao S,et al.Capecitabine and oxaliplatin for advanced esophagogastric cancer[J].N Engl Med,2008,358(1):36-46.